| Name | Doctors Bintz & Ellis |
|---|---|
| Organization Name | Doctors Bintz & Ellis |
| Location | 920 N Main St, Elk City, Oklahoma 73644 |
| Type | Supplier |
| Phone | (580) 243-1121 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug application for COL-172, a tamper-resistant, extended-release oral opioid formulation intended to treat moderate to severe pain in individuals who require around-the-clock opioid therapy for an extended period of time.
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announced today the closing of a EUR 27.5 million (USD 37 million) Series B fundraising round, which was oversubscribed.
› Verified 5 days ago
News Archive
Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug application for COL-172, a tamper-resistant, extended-release oral opioid formulation intended to treat moderate to severe pain in individuals who require around-the-clock opioid therapy for an extended period of time.
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announced today the closing of a EUR 27.5 million (USD 37 million) Series B fundraising round, which was oversubscribed.
› Verified 5 days ago
Walgreens #9874 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 115 W 3rd St, Elk City, Oklahoma 73644 Phone: (580) 225-4418 | |
Walmart Pharmacy 10-0134 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 210 Regional Dr, Elk City, Oklahoma 73644 Phone: (580) 225-1575 | |
Paul Jones Drug Type: Community/Retail Pharmacy Location: 105 N Main St, Elk City, Oklahoma 73644 Phone: (580) 225-3263 | |
Grandview Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1220 W 3rd St, Elk City, Oklahoma 73644 Phone: (580) 225-5550 | |
Heartland Medical Type: Compounding Pharmacy Location: 100 Access Rd, Elk City, Oklahoma 73644 Phone: (580) 243-5551 |